期刊文献+

甲亢与甲减患者血浆同型半胱氨酸水平和MTHFR基因多态性研究 被引量:15

Study of plasma homocystein level and methylene-tetrahydrofolate reductase (MTHFR) gene polymorphism in the patients with hyper-and hypothyroidism
原文传递
导出
摘要 本研究观察了 5 0名正常人 ,3 2例甲状腺功能减退 (甲减 )患者和 48例甲状腺功能亢进 (甲亢 )患者血浆同型半胱氨酸 (Hcy)水平和 5 ,10 亚甲基四氢叶酸还原酶 (MTHFR)基因的多态性。与正常组相比 ,血浆Hcy水平在甲减组升高 (P <0 .0 1) ,而在甲亢组降低 (P <0 .0 5 ) ;在不同甲状腺功能人群中血浆Hcy水平与FT4水平呈负相关 (r =-0 .3 5 ,P <0 .0 1)。在 3组对象中 ,MTHFR均以C/C基因型为主 ,各基因型 (C/C ,C/T ,T/T)、各等位基因 (C ,T)分布差异无显著性 ,但各组中T/T基因型者血浆Hcy水平均高于同组的其它基因型 (P <0 .0 1)。 Plasma homocystein (Hcy) level and 5,10-methylenetetrahydrofolate reductase (MTHFR) gene polymorphism were investigated in 50 normal subjects, 32 cases of hypothyroidism and 48 cases of hyperthyroidism. As compared with normal group, plasma Hcy level was increased in hypothyroidism group (P<0.01) and decreased in hyperthyroidism group (P<0.05). A negative correlation existed between plasma Hcy level and FT 4 level (r=-0.35, P<0.01). Majority of MTHFR genotypes was C/C in 3 groups and there was no distribution difference of allele C or T among 3 groups, but plasma Hcy level was higher in the carriers of genotype T/T than those of the other genotypes C/C or C/T in the same group (P<0.01).
出处 《中华内分泌代谢杂志》 CAS CSCD 北大核心 2004年第2期124-125,共2页 Chinese Journal of Endocrinology and Metabolism
关键词 血浆同型半胱氨酸 MTHFR 基因多态性 甲状腺功能减退 甲状腺功能亢进 Homocystein 5,10-methylenetetrahydrofolate reductase Polymorphism (Genetics) Hyperthyroidism Hypothyroidism
  • 相关文献

参考文献2

二级参考文献12

  • 1李光伟,Step.,L.检测人群胰岛素敏感性的一项新指数[J].中华内科杂志,1993,32(10):656-660. 被引量:2125
  • 2Susan C, Louis M, Vivian F. Hyperhomocysteinemia-an emerging and important risk factor for thromboebolic and cardiovascular disease. Clin Chem, 1996,106:709-722
  • 3Jacob S, Paul FJ, Peter WF, et al. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA, 1993,270:2693-2698.
  • 4Drzewoski J, Czupryniak L, Bud E. Total plasma homocysteine and insulin levels in type 2 diabetic patients with secondary failure to oral agents. Diabetes Care, 1999,22:2097-2103.
  • 5Lee WJ, Chen YT, Shen WH. Plasma homocysteine concentrations and insulin sensitivity in hypertensive subjects. Am J Hypertens, 2000,13(1 pt):14-20.
  • 6House JD, Jacobs RL, Stead LM, et al. Regulation of homocysteine metabolism. Adv Enzyme Regul, 1999,39:69-91.
  • 7Biaslioli S,Schiavon R.Homocysteine as a cardiovascular risk factor[].Blood Purification.2000
  • 8Okamura J,Kitamura A,Moriyama Y,et al.Plasma level of homocysteine is correlated to atherosclerosis in non-hypertensive Japanese[].Journal of Cardiovascular Risk.1999
  • 9Boushey CJ,Beresford SAA,Omenn GS,et al.A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: Probable benefits of folid acid intakes[].The Journal of The American Medical Association.1995
  • 10Ford HC,Carter MJ,Rendle MA.Serum and red cell folate and serum vitamin B12 level in hyperthyroidism[].American Journal of Hematology.1992

共引文献53

同被引文献114

引证文献15

二级引证文献63

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部